RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rekah Pharmaceutical Industry Stock

Rekah Pharmaceutical Industry Liabilities 2025

Rekah Pharmaceutical Industry Liabilities

285.29 M ILS

Ticker

REKA.TA

ISIN

IL0010810096

In 2025, Rekah Pharmaceutical Industry's total liabilities amounted to 285.29 M ILS, a -13.33% difference from the 329.18 M ILS total liabilities in the previous year.

Rekah Pharmaceutical Industry Aktienanalyse

What does Rekah Pharmaceutical Industry do?

Rekah Pharmaceutical Industry ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Rekah Pharmaceutical Industry's Liabilities

Rekah Pharmaceutical Industry's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Rekah Pharmaceutical Industry's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Rekah Pharmaceutical Industry's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Rekah Pharmaceutical Industry's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Rekah Pharmaceutical Industry’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Rekah Pharmaceutical Industry stock

What is the level of liabilities of Rekah Pharmaceutical Industry this year?

Rekah Pharmaceutical Industry has a debt balance of 285.29 M ILS this year.

What were the liabilities of Rekah Pharmaceutical Industry compared to the previous year?

The liabilities of Rekah Pharmaceutical Industry have increased by -13.33% dropped compared to the previous year.

What are the consequences of high debt for investors of Rekah Pharmaceutical Industry?

High liabilities can pose a risk for investors of Rekah Pharmaceutical Industry, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Rekah Pharmaceutical Industry?

Low liabilities mean that Rekah Pharmaceutical Industry has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Rekah Pharmaceutical Industry affect the company?

An increase in liabilities of Rekah Pharmaceutical Industry can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Rekah Pharmaceutical Industry affect the company?

A decrease in the liabilities of Rekah Pharmaceutical Industry can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Rekah Pharmaceutical Industry?

Some factors that can influence the liabilities of Rekah Pharmaceutical Industry include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Rekah Pharmaceutical Industry so important for investors?

The liabilities of Rekah Pharmaceutical Industry are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Rekah Pharmaceutical Industry take to modify the liabilities?

To change its liabilities, Rekah Pharmaceutical Industry can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Rekah Pharmaceutical Industry pay?

Over the past 12 months, Rekah Pharmaceutical Industry paid a dividend of 0.87 ILS . This corresponds to a dividend yield of about 0.07 %. For the coming 12 months, Rekah Pharmaceutical Industry is expected to pay a dividend of 0 ILS.

What is the dividend yield of Rekah Pharmaceutical Industry?

The current dividend yield of Rekah Pharmaceutical Industry is 0.07 %.

When does Rekah Pharmaceutical Industry pay dividends?

Rekah Pharmaceutical Industry pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rekah Pharmaceutical Industry?

Rekah Pharmaceutical Industry paid dividends every year for the past 0 years.

What is the dividend of Rekah Pharmaceutical Industry?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rekah Pharmaceutical Industry located?

Rekah Pharmaceutical Industry is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rekah Pharmaceutical Industry kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rekah Pharmaceutical Industry from 4/14/2022 amounting to 0.868 ILS, you needed to have the stock in your portfolio before the ex-date on 4/6/2022.

When did Rekah Pharmaceutical Industry pay the last dividend?

The last dividend was paid out on 4/14/2022.

What was the dividend of Rekah Pharmaceutical Industry in the year 2024?

In the year 2024, Rekah Pharmaceutical Industry distributed 0.868 ILS as dividends.

In which currency does Rekah Pharmaceutical Industry pay out the dividend?

The dividends of Rekah Pharmaceutical Industry are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rekah Pharmaceutical Industry

Our stock analysis for Rekah Pharmaceutical Industry Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rekah Pharmaceutical Industry Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.